Outcome of 980 Nm Diode Laser Vaporization for Benign Prostatic Hyperplasia: A Prospective Study

Overview

Journal Investig Clin Urol

Specialty Urology

Date 2018 Nov 8

PMID 30402572

Citations 4

Authors

M Hammad Mithani

Salman El Khalid

Shariq Anis Khan

Imran Sharif

Adnan Siddiq Awan

Shoaib Mithani

Irfan Majeed

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate the initial experience and outcome of photo-selective vaporization of the prostate (PVP) for benign prostatic hyperplasia (BPH) in Pakistan with the use of a 980 nm diode laser.

Materials And Methods: A prospective study was performed from November 2016 to December 2017. A total of 100 patients diagnosed with bladder outlet obstruction secondary to BPH who planned for PVP were enrolled in the study. PVP was carried out with a diode laser at 980 nm (Biolitec Diode 180W laser) in a continuous wave with a 600 nm (twister) fiber. Baseline characteristics and perioperative data were compared. Postoperative outcomes were evaluated by International Prostate Symptom Score (IPSS), post void residual (PVR) and maximum urinary flow rate (Qmax) at 3 and 6 months after surgery.

Results: The mean age was 65.82±10.42, mean prostate size was 67.35±16.42, operative time was 55.85±18.01 and total energy was 198.68±49.12 kJ. At 3 months and 6 months, significant improvements were noted (p<0.001) in IPSS 7.04±1.69 (-18.92), Qmax 19.22±4.75 mL/s (+13.09) and and PVR 18.89±5.39 mL (-112.80). Most frequent problems were burning micturition (35%) and terminal dysuria (29%). No significant difference in postoperative hemoglobin was seen in patients who were on anti-platelet drugs.

Conclusions: PVP with a diode laser is a safe and effective procedure for the treatment of BPH and is also safe in patients who are on anti-platelet agents.

Citing Articles

"Laser vaporization of the prostate: A comparative study between ejaculatory preserving and non-ejaculatory preserving technique".

Emam A, Nabil Habib K, Teama K, Samir Y, Sadeq M, Gamal M Arab J Urol. 2025; 23(1):8-15.

PMID: 39776555 PMC: 11703135. DOI: 10.1080/20905998.2024.2375677.

Quantitative investigations on light emission profiles for interstitial laser treatment.

Ta M, Kim Y, Shin H, Truong V, Kang H Biomed Opt Express. 2024; 15(12):6877-6892.

PMID: 39679393 PMC: 11640558. DOI: 10.1364/BOE.540470.

Concomitant Prostate Needle Biopsy and Laser Vaporization of the Prostate Could Be a Risk of Postoperative Hemoglobin Decline, a Retrospective Study.

Ezaki T, Hongo H, Takamatsu K, Tanaka N, Oya M Res Rep Urol. 2024; 16:123-129.

PMID: 38855129 PMC: 11162227. DOI: 10.2147/RRU.S457307.

Shedding light on polypragmasy of pain after transurethral prostate surgery procedures: a systematic review and meta-analysis.

Wroclawski M, Castellani D, Heldwein F, Teles S, Cha J, Zhao H World J Urol. 2021; 39(10):3711-3720.

PMID: 33787985 DOI: 10.1007/s00345-021-03678-6.

Outcome of a 980-nm diode laser coagulation in women with radiation-induced hemorrhagic cystitis: a single-center retrospective study.

Zhang N, Yao D, Liu X, Sun Y, Song Q Lasers Med Sci. 2020; 36(1):67-73.

PMID: 32304002 DOI: 10.1007/s10103-020-03005-2.

References

Rieken M, Bachmann A . Laser treatment of benign prostate enlargement--which laser for which prostate?. Nat Rev Urol. 2014; 11(3):142-52. DOI: 10.1038/nrurol.2014.23. View

Garraway W, Collins G, Lee R . High prevalence of benign prostatic hypertrophy in the community. Lancet. 1991; 338(8765):469-71. DOI: 10.1016/0140-6736(91)90543-x. View

Erol A, Cam K, Tekin A, Memik O, Coban S, Ozer Y . High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia. J Urol. 2009; 182(3):1078-82. DOI: 10.1016/j.juro.2009.05.043. View

Kuntz R . Laser treatment of benign prostatic hyperplasia. World J Urol. 2007; 25(3):241-7. DOI: 10.1007/s00345-007-0170-y. View

Simforoosh N, Abdi H, Kashi A, Zare S, Tabibi A, Danesh A . Open prostatectomy versus transurethral resection of the prostate, where are we standing in the new era? A randomized controlled trial. Urol J. 2010; 7(4):262-9. View

Razzaghi M, Mazloomfard M, Mokhtarpour H, Moeini A . Diode laser (980 nm) vaporization in comparison with transurethral resection of the prostate for benign prostatic hyperplasia: randomized clinical trial with 2-year follow-up. Urology. 2014; 84(3):526-32. DOI: 10.1016/j.urology.2014.05.027. View

Guess H, Arrighi H, Metter E, Fozard J . Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate. 1990; 17(3):241-6. DOI: 10.1002/pros.2990170308. View

Lusuardi L, Myatt A, Sieberer M, Jeschke S, Zimmermann R, Janetschek G . Safety and efficacy of Eraser laser enucleation of the prostate: preliminary report. J Urol. 2011; 186(5):1967-71. DOI: 10.1016/j.juro.2011.07.026. View

Muschter R . [Laser therapy for benign prostate hyperplasia]. Aktuelle Urol. 2008; 39(5):359-68. DOI: 10.1055/s-2008-1038267. View

10.

Bach T, Muschter R, Sroka R, Gravas S, Skolarikos A, Herrmann T . Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol. 2011; 61(2):317-25. DOI: 10.1016/j.eururo.2011.10.009. View

11.

Kaplan S . AUA Guidelines and Their Impact on the Management of BPH: An Update. Rev Urol. 2006; 6 Suppl 9:S46-52. PMC: 1472912. View

12.

Teichmann H, Herrmann T, Bach T . Technical aspects of lasers in urology. World J Urol. 2007; 25(3):221-5. DOI: 10.1007/s00345-007-0184-5. View

13.

Madersbacher S, Alivizatos G, Nordling J, Rioja Sanz C, Emberton M, de la Rosette J . EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol. 2004; 46(5):547-54. DOI: 10.1016/j.eururo.2004.07.016. View

14.

Kang S, Choi Y, Kim S, Cho H, Hong S, Lee J . Long-Term Follow-Up Results of Photoselective Vaporization of the Prostate with the 120 W Greenlight HPS Laser for Treatment of Benign Prostatic Hyperplasia. Korean J Urol. 2011; 52(4):260-4. PMC: 3085618. DOI: 10.4111/kju.2011.52.4.260. View

15.

Shaker H, Shoeb M, Yassin M, Shaker S . Quartz head contact laser fiber: a novel fiber for laser ablation of the prostate using the 980 nm high power diode laser. J Urol. 2011; 187(2):575-9. DOI: 10.1016/j.juro.2011.09.153. View

16.

Leonardi R . Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique. Prostate Cancer Prostatic Dis. 2009; 12(3):277-80. DOI: 10.1038/pcan.2009.5. View

17.

Rassweiler J, Teber D, Kuntz R, Hofmann R . Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol. 2006; 50(5):969-79. DOI: 10.1016/j.eururo.2005.12.042. View

18.

Ruszat R, Wyler S, Forster T, Reich O, Stief C, Gasser T . Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol. 2006; 51(4):1031-8. DOI: 10.1016/j.eururo.2006.08.006. View

19.

Yang K, Seong Y, Kim I, Han B, Kong G . Initial Experiences with a 980 nm Diode Laser for Photoselective Vaporization of the Prostate for the Treatment of Benign Prostatic Hyperplasia. Korean J Urol. 2011; 52(11):752-6. PMC: 3242988. DOI: 10.4111/kju.2011.52.11.752. View

20.

Xu A, Zou Y, Li B, Liu C, Zheng S, Li H . A randomized trial comparing diode laser enucleation of the prostate with plasmakinetic enucleation and resection of the prostate for the treatment of benign prostatic hyperplasia. J Endourol. 2013; 27(10):1254-60. DOI: 10.1089/end.2013.0107. View